The bela trial: Bosutinib versus imatinib in patients with chronic phase chronic myeloid leukemia; 18-month follow-up

Category Primary study
JournalHaematologica
Year 2011
This article has no abstract
Epistemonikos ID: c6d55cc1bb641dab70d7a65da2ede5d4b1e34449
First added on: Feb 06, 2025